There are numerous types of life science companies involved in the research and development of medical devices and new drugs. In general, biotech firms develop the device or drug and service organisations bring these products to the market. The exposures both business types face evolve during their lifecycle and the duration of the stages can vary depending on their product. Some of the main exposures can be summarised as follows during their stages of development.
if you would like more information or discuss any particular item please contact us
Navigating the changing insurance market
It’s not too late to invest in a pension if you are 50+
Owner-Controlled Insurance Programmes
COVID-19: What are the management liability implications for directors and officers?
COVID-19: What are the implications for employers as we return back to work?